ABCB1 and cancer: These compounds enhanced the cytotoxicity of several P-glycoprotein substrate anticancer drugs, and significantly reversed the multidrug resistance phenotype in P-glycoprotein-overexpressing multidrug resistant cancer cells KB-C2 and KB-V1 in a dose-dependent manner [39,40] (Figure 6).